81 related articles for article (PubMed ID: 23219015)
21. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
22. Relapsing hematologic malignancies after haploidentical hematopoietic stem cell transplantation.
Hu YX; Cui Q; Liang B; Huang H
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1099-111. PubMed ID: 21440653
[TBL] [Abstract][Full Text] [Related]
23. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
[TBL] [Abstract][Full Text] [Related]
24. T-cell therapy after hematopoietic stem cell transplantation.
Kennedy-Nasser AA; Brenner MK
Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
[TBL] [Abstract][Full Text] [Related]
25. P-selectin glycoprotein ligand-1 positive microparticles in allogeneic stem cell transplantation of hematologic malignancies.
Trummer A; De Rop C; Stadler M; Ganser A; Buchholz S
Exp Hematol; 2011 Nov; 39(11):1047-55. PubMed ID: 21864485
[TBL] [Abstract][Full Text] [Related]
26. T-cell receptor specificity of CD8(+) Tregs in allotransplantation.
Picarda E; Anegon I; Guillonneau C
Immunotherapy; 2011 Apr; 3(4 Suppl):35-7. PubMed ID: 21524168
[TBL] [Abstract][Full Text] [Related]
27. [Cellular immunotherapy of hematologic malignancies attempted using minor histocompatibility antigens as targets].
Takami A; Shiobara S
Rinsho Ketsueki; 2002 May; 43(5):360-2. PubMed ID: 12096487
[No Abstract] [Full Text] [Related]
28. T-cell receptor gene transfer for treatment of leukemia.
Heemskerk MH; Griffioen M; Falkenburg JH
Cytotherapy; 2008; 10(2):108-15. PubMed ID: 18368589
[TBL] [Abstract][Full Text] [Related]
29. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
Handgretinger R; Kurtzberg J; Egeler RM
Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
[TBL] [Abstract][Full Text] [Related]
30. [Nonmyeloablative stem cell transplantation as cancer immunotherapy].
Willems E; Baron F; Vanstraelen G; Frère P; Fillet G; Beguin Y
Rev Med Suisse; 2005 Aug; 1(30):1973-7. PubMed ID: 16200942
[TBL] [Abstract][Full Text] [Related]
31. [Antibody therapy for hematopoietic malignancies and cell surface antigen testing].
Higashi K
Rinsho Byori; 2014 Apr; 62(4):352-8. PubMed ID: 25022064
[TBL] [Abstract][Full Text] [Related]
32. Allergy and risk of hematologic malignancies: associations and mechanisms.
Musolino C; Allegra A; Minciullo PL; Gangemi S
Leuk Res; 2014 Oct; 38(10):1137-44. PubMed ID: 25171954
[TBL] [Abstract][Full Text] [Related]
33. Applications of next-generation sequencing to blood and marrow transplantation.
Chapman M; Warren EH; Wu CJ
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S151-60. PubMed ID: 22226099
[TBL] [Abstract][Full Text] [Related]
34. Guest editorial: Connecting multiple aspects of hematologic malignancies toward creation of new therapeutics.
Ishikawa F
Int J Hematol; 2017 May; 105(5):547-548. PubMed ID: 28233193
[No Abstract] [Full Text] [Related]
35. Deeper insights into hematological oncology disorders via single-cell phospho-signaling analysis.
Nolan GP
Hematology Am Soc Hematol Educ Program; 2006; ():123-7, 509. PubMed ID: 17124050
[TBL] [Abstract][Full Text] [Related]
36. Autophagy in blood cancers: biological role and therapeutic implications.
Nencioni A; Cea M; Montecucco F; Longo VD; Patrone F; Carella AM; Holyoake TL; Helgason GV
Haematologica; 2013 Sep; 98(9):1335-43. PubMed ID: 24006406
[TBL] [Abstract][Full Text] [Related]
37. [Clinical usage and future prospective of guidelines in treatment of hematological malignancies].
Usui N
Gan To Kagaku Ryoho; 2014 May; 41(5):558-9. PubMed ID: 24956626
[No Abstract] [Full Text] [Related]
38. T cell receptor usage in malignant diseases.
Halapi E; Jeddi-Tehrani M; Osterborg A; Mellstedt H
Springer Semin Immunopathol; 1999; 21(1):19-35. PubMed ID: 10389230
[No Abstract] [Full Text] [Related]
39. Immunologic Aspects of the Hematologic Neoplasms.
Jones SE; Durie BG; Salmon SE
Postgrad Med; 1973 Nov; 54(5):209-16. PubMed ID: 27393023
[TBL] [Abstract][Full Text] [Related]
40. Tracking the T-cell repertoire after adoptive therapy.
Watkins TS; Miles JJ
Clin Transl Immunology; 2017 May; 6(5):e140. PubMed ID: 28690846
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
